Strides Pharma Science on Thursday reported 45.75 per cent decline in consolidated net profit at Rs 76.98 crore for the quarter ended Se...Read More
The drug is a generic version of Japan-based Toyama Chemical's Avigan and was initially developed to treat influenza in Japan. It has sho...Read More
"Ananth will succeed our founder and incumbent CEO Arun Kumar following his appointment as the new Chief Executive by the Board
New Delhi: Drug firm Strides Pharma Science on Wednesday said it has got tentative approval from US health regulator for Diclofenac Potas...Read More
Strides Pharma Science said the site has undergone several successful USFDA inspections and has no outstanding observations.
Strides Pharma Science said the site has undergone several successful USFDA inspections and has no outstanding observations